Q2B-17455-35697 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-30
Dose 1 — Pfizer-BioNTech
2021-01-20
Dose 2 — Pfizer-BioNTech
2022-01-16
Registered in v-safe
2022-01-16
Dose 3 — Moderna
2022-01-17
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-01-18
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2022-01-19
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-20
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-21
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-22
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-23
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-30
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-02-06
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-13
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-30	Pfizer-BioNTech	No
2	2021-01-20	Pfizer-BioNTech	No
3	2022-01-16	Moderna	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

No MedDRA codes.